LCBVX
Price
$39.48
Change
+$0.23 (+0.59%)
Updated
Jun 3 closing price
Net Assets
2.27B
RMEBX
Price
$57.68
Change
+$0.25 (+0.44%)
Updated
Jun 3 closing price
Net Assets
104.92B
Interact to see
Advertisement

LCBVX vs RMEBX

Header iconLCBVX vs RMEBX Comparison
Open Charts LCBVX vs RMEBXBanner chart's image
ClearBridge Large Cap Value R
Price$39.48
Change+$0.23 (+0.59%)
VolumeN/A
Net Assets2.27B
American Funds American Mutual R2E
Price$57.68
Change+$0.25 (+0.44%)
VolumeN/A
Net Assets104.92B
LCBVX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LCBVX vs. RMEBX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCBVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. LCBVX (2.27B). RMEBX pays higher dividends than LCBVX: RMEBX (1.16) vs LCBVX (0.71). LCBVX was incepted earlier than RMEBX: LCBVX (11 years) vs RMEBX (11 years). LCBVX (1.23) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. LCBVX (22.00). LCBVX has a lower initial minimum investment than RMEBX: LCBVX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.18 vs. LCBVX (-6.20). RMEBX return over 5 years is better than : 52.34 vs. LCBVX (32.65).
LCBVXRMEBXLCBVX / RMEBX
Total Expense Ratio1.231.07115%
Annual Report Gross Expense Ratio1.231.07115%
Fund Existence11 years11 years-
Gain YTD-0.5254.892-11%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.27B105B2%
Annual Yield % from dividends0.711.1661%
Returns for 1 year-6.208.18-76%
Returns for 3 years8.0217.5246%
Returns for 5 years32.6552.3462%
Returns for 10 years41.3966.6762%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALIX13.280.08
+0.61%
Value Line Capital Appreciation Investor
RSIPX14.57N/A
N/A
Columbia Disciplined Core Inst2
RYWAX49.70N/A
N/A
Rydex S&P SmallCap 600 Pure Growth H
JEMNX9.91N/A
N/A
JHancock Emerging Markets Equity R4
GQFPX12.21N/A
N/A
GQG Partners Global Quality Value Fd Inv